Abstract
Hypertension, particularly systolic hypertension, afflicts over 50% of postmenopausal women and is an important risk factor for cardiovascular disease in this group. Hormone replacement therapy with estrogen or an estrogen/progestin combination does not alter blood pressure but has beneficial effects on other cardiovascular risk factors, so should be considered in all postmenopausal women unless contraindicated.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
